{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:45:49Z","timestamp":1770342349473,"version":"3.49.0"},"reference-count":36,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1517\/17425255.2.3.419","type":"journal-article","created":{"date-parts":[[2006,5,30]],"date-time":"2006-05-30T06:55:47Z","timestamp":1148972147000},"page":"419-427","source":"Crossref","is-referenced-by-count":76,"title":["The use of isotopes in the determination of absolute bioavailability of drugs in humans"],"prefix":"10.1517","volume":"2","author":[{"given":"Graham","family":"Lappin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Colin","family":"Garner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2006,5,30]]},"reference":[{"key":"CIT0001","unstructured":"FDA US DEPARTMENT OF HEALTH AND HUMAN SERVICES: Code of Federal Regulations, Title 21, Subchapter D Drugs for Human Use, part 320 Bioavailability and Bioequivalence Requirements."},{"key":"CIT0002","unstructured":"FDA US DEPARTMENT OF HEALTH AND HUMAN SERVICES: CDER, Waiver ofinvivobioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceuticals classification system."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1023\/A:1013319408893"},{"key":"CIT0004","first-page":"159","volume":"103","author":"RAJARAM","year":"2004","journal-title":"Stud. Health Technol. Inform."},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/BF01063122"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1007\/BF01062667"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1007\/BF01068416"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cpt1975185part1613","volume":"18","author":"STRONG","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2728(00)00058-X"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2004.08.027"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1021\/bi00328a005"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1994.1193"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1993.tb03910.x"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1177\/00912709922008489"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1007\/s002280000244"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1128\/AAC.43.10.2451","volume":"43","author":"PRESTON","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1007\/BF00202172"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00910.x"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1007\/BF01060015"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1007\/BF03188865"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04079.x"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199018060-00001"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-7192(03)80012-8"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-003-2348-5"},{"key":"CIT0025","volume-title":"Radiotracers in drug development","author":"WHITBY","year":"2006"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02709.x"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03679.x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1007\/BF01061722"},{"key":"CIT0029","first-page":"458","volume":"11","author":"COTLER","year":"1983","journal-title":"Drug Metab. Dispos."},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197803060-00005"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1177\/0091270005280051"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1021\/ac030181y"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1177\/0091270006286849"},{"key":"CIT0034","first-page":"1329","volume":"25","author":"KWAN","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.1.1.23"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-58823"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/17425255.2.3.419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T22:35:49Z","timestamp":1555626949000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/17425255.2.3.419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,30]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,5,30]]},"published-print":{"date-parts":[[2006,6]]}},"alternative-id":["10.1517\/17425255.2.3.419"],"URL":"https:\/\/doi.org\/10.1517\/17425255.2.3.419","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,30]]}}}